Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bunanserin vs risperidone in schizophrenia
CTR20131380Phase 3Completed
- Sponsor
- Hengrui Therapeutics
- Start
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of blonanserin in schizophrenia, sponsored by Hengrui Therapeutics. Started Sep 2014; status: completed.
02
Drugs
blonanserin
03
Conditions
schizophrenia
Beyond the preview
Go deeper on CTR20131380.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131380.